Biocon Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is MYCOPHENOLATE SODIUM, with a corresponding US DMF Number 23519.
Remarkably, this DMF maintains an Active status since its submission on February 08, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 09, 2013, and payment made on December 14, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II